PB2294: DOSE-ADJUSTED EDOCH AS FIRST-LINE THERAPY IMPROVED PROGNOSIS OF ADULT T-CELL LEUKEMIA/LYMPHOMA: A 11-YEAR MULTICENTER RETROSPECTIVE STUDY IN CHINA - Luting Luo; Jiazheng LI; Wanying Liu; Yanxin Chen; Zhengjun Wu; Chengjun Nie; Xiaoyun Zheng; Renli Chen; Ting Yang; Jianda Hu (HemaSphere, 2023)